Ambition: Change Diabetes in Cambodia

Primary tabs

Novo Nordisk
Keywords: Volunteerism & Community Engagement | Community | Corporate Social Responsibility | Green Professionals | Novo Nordsik | Positive Change | Social Development | Sustainability Business | Sustainable Solutions | access to health

Ambition: Change Diabetes in Cambodia

Novo Nordisk’s delivers a one-stop diabetes care to people’s doorstep
tweet me:
Novo Nordisk’s delivers a one-stop #diabetes care to people’s doorstep http://3bl.me/ymsbcs #access #health
Press Release
Monday, April 2, 2012 - 2:00pm

(3BL Media) April 2, 2012 - On 1 April 2012, Novo Nordisk launched the third ‘Diabetes Care’ mobile clinics in Cambodia. The mobile clinics are part of the company’s strategy in Cambodia to improve access to healthcare and make diabetes treatment affordable in rural communities. Essential medication, including insulin for $5 a month from Novo Nordisk, is made available for managing diabetes.

One year ago, Novo Nordisk set out to address the growing challenges people with diabetes are facing in Cambodia. With a rising prevalence rate in both rural and urban areas, Cambodia was facing low diabetes awareness, very few doctors trained in diabetes, a large ‘isolated’ rural population and many people having difficulty affording medicine. To meet these challenges, Novo Nordisk launched a programme to drive diabetes awareness and education of physicians, provide sustainable access to care and medicine and support and drive National Diabetes Policy.

Novo Nordisk’s solution was to deliver a one-stop diabetes care to people’s doorstep. 

To find out more about how Novo Nordisk is changing diabetes in Cambodia, click here.

 

About Novo Nordisk
Novo Nordisk is a global healthcare company with nearly 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs more than 32,000 employees in 75 countries, and markets its products in 190 countries. Novo Nordisk's B shares are listed on the NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2012, Novo Nordisk receive top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. Novo Nordisk is listed in the 2010/2011 Dow Jones Sustainability Indices with a gold class rating.

For more information, visit novonordisk.com/sustainability.